-+ 0.00%
-+ 0.00%
-+ 0.00%

The US Food and Drug Administration is closely monitoring the risk of tumor formation in other similar adeno-associated virus vector-based gene therapy programs.

Zhitongcaijing·11/07/2026 01:33:06
Listen to the news
The US Food and Drug Administration is closely monitoring the risk of tumor formation in other similar adeno-associated virus vector-based gene therapy programs.